I
n the pancreas, the islets of Langerhans, mainly insulin-secreting ␤-cells, accumulate very high amounts of zinc (1) . Insulin is generally believed to be stored inside secretory vesicles as a solid hexamer bound with two Zn 2ϩ ions per hexamer (2-4). Insulin, produced and stored in pancreatic ␤-cells, is released by exocytosis in response to external stimuli, such as elevated glucose concentrations or arginine. When exocytosis of insulin occurs, insulin granules fuse with the ␤-cell plasma membrane and release their contents, insulin as well as zinc, into the circulation (5) . Moreover, there appears to be a complex relationship between zinc and both type 1 and type 2 diabetes because several complications of diabetes may be mediated through oxidative stress, which is amplified in part by zinc deficiency (6) . Hence, zinc is an important mediator of insulin storage and secretion, and ␤-cells undoubtedly need very efficient and specialized transporters to accumulate zinc in secretion vesicles.
In the body, intracellular zinc concentration and localization are strictly regulated (7, 8) . The two main components involved in zinc homeostasis are metallothioneins and membrane transporters (9, 10) . Metallothioneins are implied in intracellular zinc storage and trafficking, whereas membrane transporters ensure zinc carriage across biological membranes. Zip proteins allow intracellular uptake of zinc (11, 12) , whereas zinc transporter (ZnT) proteins permit cellular efflux of zinc into extracellular matrix or into intracellular vesicles. In mammalian cells, seven homologous zinc export proteins, named ZnT-1 to -7, have been described (for review see Chimienti et al. [13] ). These proteins are members of the SLC30 (solute carrier) subfamily of the CDF (cation diffusion facilitator) family and share the same predicted structure, with six membrane-spanning domains and a histidine-rich intracellular loop between helices IV and V, except for ZnT-6, which retains a serine-rich loop from prokaryotic sequences. ZnT-1 and -2, located either in the plasma membrane or in acidic endosomal/lysosomal vesicles, respectively, are ZnTs that confer zinc resistance by ensuring zinc efflux from the cytoplasm (14, 15) . ZnT-3 and -4, cloned in humans, are also localized in intracellular vesicles, but are more dedicated to secretion pathways (16, 17) . ZnT-3 is tissue specific and mainly located in brain, in the membranes of zinc-rich synaptic vesicles within the mossy fiber boutons of the hippocampus (18) , and in testis (16) . Conversely, ZnT-4 is largely expressed (19) . However, higher levels of ZnT-4 were found in brain and epithelial cells, and this transporter has been shown to be essential in mammary epithelia for regulating milk zinc content (20) . ZnT-5 is a ZnT mainly localized in the Golgi apparatus and expressed in pancreas (21) . However, it is also strongly expressed in liver, kidney, muscle, and heart (21). Moreover, ZnT-5 null mice have been shown to suffer osteopenia and male-specific sudden cardiac death in mice lacking the SLC30A5 gene, suggesting that the ZnT-5 protein plays an important role in the maintenance of cells involved in the cardiac conduction system (22) . Two other transporters, ZnT-6 and -7, described very recently (23, 24) , are expressed in various tissues and both localized to the Golgi apparatus. The intracellular distribution of ZnT-6 and ZnT-4 has been shown to be regulated by zinc, whereas exposure of ZnT-7-expressing cells to zinc causes an accumulation of zinc in the Golgi apparatus.
The zinc content in the pancreatic ␤-cell is among the highest of the body, but little information about which proteins might handle zinc in the ␤-cell is available. Previous studies (21, 25) have determined that some ZnT genes are involved in zinc uptake and storage in pancreatic cells and that their expression is developmentally regulated in the islet.
We report here for the first time the identification and cloning of a pancreatic-specific ZnT belonging to the ZnT protein family, named ZnT-8, and localized in insulin secretory granules. This new ZnT may be a major component for providing zinc to insulin maturation and/or storage processes in insulin-secreting pancreatic ␤-cells.
RESEARCH DESIGN AND METHODS
All chemicals were of reagent grade and from Sigma (St. Quentin-Fallavier, France) or Merck (Grenoble, France). Zinquin ethyl ester was purchased from TRC (North York, Canada). Data mining and bioinformatics. BLASTN or TBLASTN (26) analysis was performed on the National Center for Biotechnology Information (NCBI) web server (http://www.ncbi.nlm.nih.gov/blast/blast.cgi) and the ENSEMBL web server (http://www.ensembl.org/) with human ZnT-1 (AF323590 and Q9Y6M5), mouse ZnT-1 (U17132 and Q60738), rat ZnT-1 (U17133 and Q62720), rat ZnT-2 (U50927 and Q62941), human ZnT-3 (NM_003459 and Q99726), mouse ZnT-3 (U76007 and P97441), human ZnT-4 (AF025409 and O14863), mouse ZnT-4 (O35149), rat ZnT-4 (O55174), human ZnT-5 (AY089991 and AAM09099), human ZnT-6 (NM_017964 and NP_060434), and human ZnT-7 (AY094606 and AAM21969) DNA or protein sequences. The predicted ZnT-8 sequence (open reading frame and 3Ј untranslated region) was used for a BLASTN search of the human expressed sequence tag (EST) database (release 030802). The significant ESTs (a bit score Ͼ50 and an E value Ͻ0.0001) were sorted, and information regarding each cDNA library was retrieved from either the human Unigene databank (http://www.ncbi.nlm.nih.gov/Unigene) or from the respective company catalog. The ESTs were also analyzed by the Gene2EST program (http://woody.embl-heidelberg.de/gene2est) to examine the 5Ј region and the putative splicing variants (27) . Homo sapiens ZnT protein sequences were aligned using the ClustalW program (28) . For phylogenetic analysis, bootstrapping (2,000 replicate sets) and calculation of the consensus tree were performed with the DAMBE program by the neighbor-joining method (29) . Bootstrap analysis is based on multiple resampling of the original data and is the most common method for estimating the degree of confidence in the topology of phylogenetic trees. The TMpred computer program (http:// www.ch.embnet.org/software/TMPRED_form.html) was used to analyze and predict the transmembrane potential of the predicted protein sequence (30) . Cell culture methods. HeLa epithelial cells (American Type Culture Collection [ATCC] number CCL-2) were grown in Opti-MEM medium (modified Eagle's medium; Invitrogen, Carlsbad, CA) supplemented with 5% heatinactivated FCS, 2 mmol/l glutamine, 100 units/ml penicillin, and 100 g/ml streptomycin. Aliquots of the INS-1 cell line (31) were a gift from P.Y. Benhamou (Hospital of Grenoble, Grenoble, France), with the courtesy of Dr. W. Pralong (Lausanne, Switzerland). INS-1 cells were grown at 37°C, in a 5% CO 2 -enriched atmosphere, in RPMI 1640 medium (Invitrogen), including 10% heat-inactivated fetal bovine serum (Invitrogen), 50 mol/l 2-mercaptoethanol, 1 mmol/l Na-pyruvate, 10 mmol/l HEPES, 2 mmol/l L-glutamine, 100 units/ml penicillin, and 100 g/ml streptomycin and routinely split at a 1:5 ratio. Plasmid construction and generation of stable cell lines. Full-length ZnT-8 cDNA was isolated by RT-PCR amplification from human islet total RNA with specific primers containing 5Ј-EcoRI and 3Ј-XbaI restriction sites. The Expressing cells were selected using a medium containing 350 g/ml G418 (Roche, Meylan, France). The ZnT-8-EGFP-and control EGFP-expressing HeLa stable cell lines were generated by transfecting pZnT-8-EGFP or pEGFP into HeLa cells using Lipofectamine Plus (Invitrogen). The stable cell lines were selected by culturing the cells in the medium containing 700 g/ml G418 (Roche) and cloned using a cell sorter. After amplification of clones, the expression of the fusion protein was controlled under fluorescence microscopy, and the size of the fusion product was verified by Western blotting using a specific anti-EGFP antibody (Invitrogen). For Golgi apparatus localization, transient transfections with pECFP-Golgi (Clontech) were performed as described above on the ZnT-8-EGFP-expressing HeLa stable cell line. Islet of Langerhans and cell RNA extraction. Total RNA isolated from human islets using the RNaid Plus extraction kit (Qbiogene, Carlsbad, CA) and total fetal pancreas RNAs (Stratagene, La Jolla, CA) were kindly provided by Dr. F. De Fraipont (Hospital of Grenoble, Grenoble, France). Prior to RNA extraction, INS-1 or HeLa cells were washed twice with cold PBS, scraped, and centrifuged for 3 min at 2,000g. Total RNA was extracted from the cell pellet by the RNA extraction kit (Roche) as described by the manufacturer. The RNA was quantified and stored in aliquots at Ϫ80°C. ZnT-8 expression in different tissues. The presence and level of ZnT-8 mRNA were determined by PCR amplification of cDNA libraries from different human tissues (Rapid-Scan; Origene Technologies, Rockville, MD) or by RT-PCR on total RNAs prepared from islets of Langerhans or cultured cells. The specific primers were: 5Ј-GAT GCT GCC CAC CTC TTA ATT GAC and 5Ј-CCA AGA CCA GGA TGG AAA AGA TGA for ZnT-8 and 5Ј-CCA AGG CCA ACC GCG AGA AGA TGA C and 5Ј-AGG GTA CAT GGT GGT GCC GCC AGA C for ␤-actin. The products were analyzed by agarose gel electrophoresis, stained with ethidium bromide, and photographed under ultraviolet light. Immunofluorescence. pZnT-8-EGFP-expressing INS-1 cells were seeded onto glass coverslips and allowed to attach for 72 h. Cells were fixed in 4% formaldehyde in PBS for 15 min and permeabilized in PBS containing 0.1% Triton X-100. Cells were then blocked in 2% BSA in PBS for 1 h, followed by the addition of a monoclonal anti-insulin antibody (Sigma, Lyon, France) diluted 1:2,000 in blocking buffer. Cells were washed in blocking buffer, incubated in donkey anti-mouse IgG-Cy3 conjugate (Jackson ImmunoResearch Laboratory, West Grove, PA), and diluted in blocking buffer at 1:300. Cells were washed in PBS, followed by a final wash in ddH 2 O. Coverslips were mounted onto glass slides using FluorSave (Calbiochem, La Jolla, CA) and photographed using a Leica confocal fluorescence microscope. Zinquin staining. Zinquin staining was performed using pEGFP-or pZnT-8-EGFP-transfected cells. Cells were grown in Labtek II chambered cover glass systems (Nunc, Rochester, NY) for 48 h and then treated with 0 or 75 mol/l ZnSO 4 for 3 h in the culture medium. After ZnSO 4 treatment, cells were rinsed three times with PBS, pH 7.4, and then incubated in Ca 2ϩ -Mg 2ϩ PBS containing 5 mol/l zinquin ethyl ester for 20 min. The cells were then washed with PBS, pH 7.4, and examined under a Zeiss Axiovert 200 fluorescence microscope ( exc 365 nm; em 420 nm). Digital images were captured with a cooled charge-coupled device camera (Hamamatsu C5935; Hamamatsu, Hamamatsu City, Japan).
Accession numbers. The sequence data reported for human ZnT-8 was submitted to GenBank under the following accession number: AY117411.
RESULTS
Genomic organization of ZnT-8 gene. We used a datamining strategy using the different already-known ZnT cDNA and protein sequences: human, mouse, and rat ZnT-1; rat ZnT-2; human ZnT-3; human, mouse, and rat ZnT-4; human ZnT-5; human ZnT-6; and human ZnT-7. These sequences were used in a BLASTN or TBLASTN search of the Human Genome Project databank. Among the results, we discovered a new sequence of a putative ZnT, named ZnT-8. The gene coding for ZnT-8 was designated SLC30A8 by the Human Genome Organization (HUGO), and applications were patented (32) . A human ZnT-8 DNA coding sequence was found in the contig AC027419, which allowed us to localize SLC30A8 to human chromosome 8 at the position q24.11. The gene contained eight exons, spanned 37 kb, and encoded a 369 -amino acid protein (Fig. 1A and B) . RT-PCR analysis and examination of EST sequences were used to confirm the structure of the human SLC30A8 gene (Fig. 2) , and the transcription start site was mapped on EST BM565086. We also identified orthologues of SLC30A8 in mouse and rat genomes. Mouse ZnT-8 gene was located at the position 15D1 in the contig AC127562.3.1.173351. The predicted protein shares 80% identity with human ZnT-8 (Fig. 1C) . The rat ZnT-8 gene was located at the position 7q31 in the contig RNOR03308537.1.41192, and the predicted protein shares a 76% amino acid identity with human ZnT-8 (Fig.  1C) . Primary structure analysis of Znt-8 protein.
The transmembrane topology of the protein was assessed using the TMPRED computer program (30) . ZnT-8 was predicted to adopt the same topology as the other ZnT proteins with six transmembrane helixes (Fig. 3A) . In addition, the predicted sequence contains a histidine-rich domain between the fourth and the fifth helix (Fig. 3B) . Figure 3C shows the alignment of the ZnT histidine-rich domains. It is noteworthy that ZnT-6 retains serine residues from a prokaryotic ancestor instead of a histidine-rich domain. These two features are highly conserved among members of the ZnT family. A phylogenetic tree for all identified human ZnT family proteins was generated using the program DAMBE (29) (Fig. 3D) . Analysis of the tree indicated that ZnT-5, -6, 
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and -7 cluster closely together because they may all be involved in Golgi accumulation of zinc in many cell types. The plasma membrane transporter ZnT-1 is more distant from all other ZnT proteins. ZnT-8 is closely related to ZnT-2, -3, and -4, all of which have already been involved in secretory/synaptic vesicle transport and lysosomal/endosomal zinc storage in different cells. In this subfamily, ZnT-2 and -3 are closer to ZnT-8 than ZnT-4. A PROSITE database scan indicated that the human ZnT-8 protein contains several putative signals: three potential protein kinase C phosphorylation sites, one casein kinase II phosphorylation site, one tyrosine kinase phosphorylation site, one cAMP-and cyclic guanosine monophosphate (cGMP)-dependent protein kinase phosphorylation site, two Nglycosylation sites, and two N-myristoylation sites. Specific tissue expression of ZnT-8 mRNA. To confirm the expression of this new ZnT, we designed oligonucleotides from the predicted mRNA sequence and performed PCR amplification on cDNA prepared from different human tissues. A PCR product was amplified and detected only from a pancreas cDNA sample (Fig. 4A) . This product had the expected size of 475 bp and was sequenced to confirm the specificity of the PCR amplification. We also designed oligonucleotides for full-length cDNA amplification and sequenced the PCR product to confirm the predicted mRNA splicing for ZnT-8 (data not shown). Since the ZnT-8 sequence was only detected in pancreas cDNA, we performed the same reaction on total RNAs isolated from the HeLa and insulin-secreting INS-1 cell lines, as well as total RNAs isolated from human fetal pancreas and human islets of Langerhans (Fig. 4B) . ZnT-8 mRNA was not detected in HeLa cells, but was present in other pancreatic RNAs, from human tissue to cultured cells, thus confirming the tissue specificity of ZnT-8 mRNA expression.
Localization of ZnT-8 to the insulin granules of INS-1 cells. Previous studies have demonstrated that other
ZnT proteins are localized to specific subcellular compartments for zinc transport in mammalian cells. Therefore, we sought to determine the subcellular localization of ZnT-8 in cells relevant to its pancreatic expression. For this purpose, we expressed the ZnT-8 protein as a fusion with the EGFP in the insulin-secreting INS-1 cells. After transfection and selection, we observed in live cells a strong punctuate staining pattern in the cytoplasm, an indication of cytoplasmic vesicle localization (Fig. 5A) . To further determine the exact nature of these ZnT-8 -containing granules, we compared the subcellular staining patterns of a ZnT-8-EGFP fusion protein with those of insulin in pancreatic insulinoma INS-1 cells. To this end, ZnT-8-EGFP-expressing INS-1 cells were fixed, and insulin was detected using a monoclonal anti-insulin antibody. As demonstrated by confocal immunofluorescence microscopy assay, the punctuate staining of ZnT-8 was almost completely coincident with that of insulin (Fig. 5B) , strongly suggesting that ZnT-8 is associated with the insulin granule secretory pathway. 
F. CHIMIENTI AND ASSOCIATES
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Accumulation of zinc in ZnT-8-EGFP-expressing HeLa cells. To confirm the expression of this new ZnT and possibly localize ZnT-8 to a specific compartment, we stably expressed the EGFP-tagged ZnT-8 protein in HeLa cells. In these cells, which lack the insulin secretory pathway, ZnT-8-EGFP sited mainly into intracellular vesicles and to the plasma membrane, with a stronger signal at cell-cell contact. Whereas, to the contrary, control (EGFPalone) cells displayed a diffuse staining (Fig. 6A) . Some ZnTs have been recently shown to be expressed in specific subcellular compartments. In particular, ZnT-5 was found to be abundantly expressed in the Golgi apparatus in HeLa cells. To assess a potential colocalization between these two ZnTs, we transiently transfected ZnT-8-EGFP-expressing HeLa cells with the Golgi marker pECFP (enhanced cyan fluorescent protein)-Golgi. The fluorescence microscopy assay revealed that in HeLa cells, the ZnT-8-EGFP staining differs completely from the Golgi apparatus (Fig. 6B) , which is strictly restricted to a perinuclear region. Hence the ZnT-8 protein is not part of the Golgi apparatus, contrary to what has been found for ZnT-5, but is found in intracellular vesicles and at the plasma membrane.
To further examine the function of ZnT-8 in the translocation of cytoplasmic zinc into the ZnT-8-EGFP-expressing HeLa cells, we used zinquin, a zinc-specific fluorescent dye to detect under fluorescence microscopy the accumulation of labile zinc. To compare signal intensity between different conditions, all digital images were captured with the same integration time. When control HeLa cells were grown in the culture medium, a signal was hardly detected (Fig. 7A) , whereas ZnT-8-EGFP-expressing HeLa cells displayed membrane and intracellular staining (Fig. 7C) . Signal intensity was slightly increased when all HeLa cells were treated with 75 mol/l ZnSO 4 for 3 h (Fig. 7B ), but this increase was dramatically more pronounced in ZnT-8-EGFP-expressing HeLa cells (Fig. 7D) . Hence, the level of zinc accumulation is dependent on the expression of ZnT-8-EGFP and the concentration of zinc in the culture medium.
Taken together, these results strongly suggest that the ZnT-8-EGFP protein is functional in INS-1 and HeLa cells 
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and is a ZnT that facilitates the rapid zinc accumulation in intracellular vesicles in these cells.
DISCUSSION
To date, genetic and genomic studies (14 -16,20,21,23,24) have identified seven proteins involved in zinc extrusion in mammalian cells. In this study, we describe the discovery of a new gene, SLC30A8, which encodes ZnT-8, a novel member of the ZnT family. ZnT-8 shares many properties with the other members of the ZnT family, including six predicted transmembrane domains and a histidine-rich loop between transmembrane domains IV and V. We also demonstrate that the expression of the SLC30A8 gene is strictly restricted to the pancreas islet cells and that a fusion protein was colocalized with insulin secretory granules in the rat insulin-secreting INS-1 cell line, one of the few existing models of the ␤-cell. The ZnT proteins have been shown to play roles in transporting zinc out of cells or sequestrating zinc into intracellular compartments. We show that ZnT-8 leads to zinc accumulation in intracellular vesicles when overexpressed in HeLa cells. This finding, combined with the similarity in the amino acid sequence and predicted secondary structures to the previously described ZnT proteins, strongly indicates that ZnT-8 is a ZnT involved in the translocation of the cytoplasmic zinc into intracellular vesicles.
Contrary to that of ZnT-1, ZnT-5 and -7 (14, 15, 21, 24) , which localized on the plasma membrane or in the Golgi apparatus, respectively, in different cell lines, the vesicular compartment where ZnT-8-EGFP localized appears different in the insulinoma INS-1 cell line and in HeLa cells, which lack the insulin secretion pathway. Furthermore, ZnT-5 is widely expressed in tissues but is specifically detected in insulin-containing ␤-cells and not in other endocrine cell types (21) . ZnT-8 is specifically expressed in the pancreas and localized to insulin secretory granules in INS-1 cells. Therefore, it may act in synergy with ZnT-5 in the insulin synthesis/secretion pathway, as well as possibly participate in intracellular free-zinc homeostasis. The presence of more than one ZnT in pancreatic cells is not surprising. They are present in different cell compartments, i.e., ZnT-1 to the plasma membrane and ZnT-5 in the Golgi apparatus, and are essential to buffer cytosolic zinc and to transport zinc to correct sites in the cell.
In addition, phylogenetic analysis demonstrates that ZnT-8 is closely related to ZnT-2, -3, and -4, a subfamily of ZnT proteins that has already been involved in secretory/synaptic vesicle transport and lysosomal/endosomal zinc storage in different cells (for review see Kambe et al. [21] ). Taken together, these data strongly suggest that ZnT-8 is involved in transporting zinc into a unique vesicular compartment, the insulin secretory granules of pancreatic ␤-cells. Therefore, ZnT-8 may play an important role in insulin synthesis, storage, and/or secretion.
Zinc is known to play a key role in the synthesis and action of insulin, both physiologically and in the pathogenic state of diabetes. Zinc is required for insulin synthesis and storage (3), and thus large amounts of zinc are released with insulin after glucose stimulation (2) . Additionally, considering the anatomical structure of the islets of Langerhans, it is likely that the ␤-cells also modulate the function of neighboring cells via paracrine/autocrine interactions. Indeed, a recent report indicates that zinc released from activated insulin-secreting ␤-cells is implied in the suppression of glucagon-secreting activity of neighboring ␣-cells (33) , an effect comparable with that of zinc in neurons, where synaptically released zinc functions as a conventional synaptic neurotransmitter or neuromodulator (34). Thus, zinc is of prime importance for both insulin secretion by ␤-cells and islet cell paracrine/autocrine communication.
Regarding pathological states, there appears to be a complex interrelationship between zinc and both type 1 and type 2 diabetes. Modulations of the zinc content in the whole body induced in the pathological state of diabetes can have primary effects and secondary complications (for review see Chausmer [6] ). The predominant effect of diabetes on zinc homeostasis is hypozincemia, which may result from hyperzincuria, decreased absorption, or both. Forty years ago, Quarterman et al. (35) demonstrated that zinc-deprived rats had an impaired response of insulin secretion to glucose stimulation, and other studies (36) indicated a decreased islet cell insulin content in zincdeficiency states. Conversely, zinc supplementation markedly ameliorated the hyperglycemia of diabetic mice (37) . Moreover, the intracellular zinc depletion induced by diabetes may have other effects. Excessive apoptosis of the pancreatic ␤-cell has been associated with diabetes (for review see Chandra et al. [38] ). Because zinc is a potent inhibitor of apoptosis (8, 39) , zinc depletion by itself can enhance apoptosis in ␤-cells.
In conclusion, zinc plays a significant role in all processes of insulin trafficking, i.e., synthesis, storage, and secretion, and is also important in islet of Langerhans cell communication. Additionally, zinc modulations can have deleterious effects in diabetes. We describe here for the first time a islets of Langerhans-specific ZnT, expressed in ␤-cells, which facilitates the accumulation of zinc from the cytoplasm into intracellular vesicles. Thus, ZnT-8 may be a major component for providing zinc to insulin maturation and/or storage processes in insulin-secreting pancreatic ␤-cells.
